Patent 9982037 was granted and assigned to Massachusetts Institute of Technology on May, 2018 by the United States Patent and Trademark Office.
The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza.